STP938
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for STP938, covering 2026-01-28 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas [Phase 1, Phase 2]